Akebia Therapeutics Inc (AKBA)

Operating Expenses

$189.22M

TTM · Period ending: · USD

AKBA logo

AKBA Operating Expenses

Latest reported$189.22M
AKBA TTM Operating Expenses ($15.93M → $189.22M)
High-resolution chart · PNG

AKBA operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Akebia Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
189,224,000
182,658,000
173,233,000
159,716,000
150,872,000
156,483,000
165,114,000
160,832,000
162,133,000
166,146,000
166,731,000
195,199,000
218,964,000
244,566,000
288,001,000
314,669,000
341,529,000
347,598,000
341,384,000
365,370,000
365,410,000
374,996,000
412,252,000
451,387,000
473,268,000
506,580,000
504,068,000
491,955,000
463,348,000
425,146,000
378,196,000
311,844,000
296,291,000
262,492,000
257,901,000
221,531,000
192,254,000
177,786,000
137,995,000
118,466,000
101,962,000
76,663,000
61,513,000
52,070,000
41,976,000
38,926,996
37,940,243
33,534,464
27,984,464
23,265,251
15,932,722
11,260,996
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.